23andMe Holding Co. (ME) financial statements (2022 and earlier)
Company profile
| Business Address |
223 NORTH MATHILDA AVENUE SUNNYVALE, CA 94086 |
| State of Incorp. | |
| Fiscal Year End | March 31 |
| SIC | 2834 - Pharmaceutical Preparations (benchmarking) |
| More info | Complete financial analysis Financial benchmarking |
Balance sheet (Statement of financial position) ($ in millions)
| 12/31/2021 TTM | 12/31/2020 | |||
|---|---|---|---|---|
| ASSETS | ||||
| Current Assets | ||||
| Cash, cash equivalents, and short-term investments | 586 | 1 | ||
| Cash and cash equivalents | 586 | 1 | ||
| Restricted cash and investments | 2 | |||
| Receivables | 24 | |||
| Inventory, net of allowances, customer advances and progress billings | 17 | |||
| Inventory | 17 | |||
| Prepaid expense | 0 | |||
| Deferred costs | 16 | |||
| Other undisclosed current assets | 25 | |||
| Total current assets: | 670 | 1 | ||
| Noncurrent Assets | ||||
| Operating lease, right-of-use asset | 57 | |||
| Property, plant and equipment | 52 | |||
| Intangible assets, net (including goodwill) | 430 | |||
| Goodwill | 352 | |||
| Intangible assets, net (excluding goodwill) | 78 | |||
| Assets held-in-trust | 509 | |||
| Restricted cash and investments | 7 | |||
| Other noncurrent assets | 1 | |||
| Other undisclosed noncurrent assets | 8 | |||
| Total noncurrent assets: | 556 | 509 | ||
| TOTAL ASSETS: | 1,226 | 510 | ||
| LIABILITIES AND EQUITY | ||||
| Liabilities | ||||
| Current Liabilities | ||||
| Accounts payable and accrued liabilities | 61 | 0 | ||
| Accounts payable | 14 | |||
| Accrued liabilities | 46 | 0 | ||
| Deferred revenue | 112 | |||
| Debt | 2 | |||
| Deferred compensation liability | 18 | |||
| Other undisclosed current liabilities | 7 | |||
| Total current liabilities: | 180 | 19 | ||
| Noncurrent Liabilities | ||||
| Long-term debt and lease obligation | 81 | |||
| Operating lease, liability | 81 | |||
| Liabilities, other than long-term debt | 5 | |||
| Other liabilities | 5 | |||
| Total noncurrent liabilities: | 86 | |||
| Other undisclosed liabilities | 69 | |||
| Total liabilities: | 265 | 88 | ||
| Stockholders' equity | ||||
| Stockholders' equity attributable to parent, including: | 961 | 5 | ||
| Common stock | 0 | 0 | ||
| Additional paid in capital | 2,086 | 54 | ||
| Accumulated other comprehensive loss | (0) | |||
| Accumulated deficit | (1,125) | (49) | ||
| Other undisclosed stockholders' equity attributable to parent | 0 | |||
| Other undisclosed stockholders' equity | 417 | |||
| Total stockholders' equity: | 961 | 422 | ||
| TOTAL LIABILITIES AND EQUITY: | 1,226 | 510 | ||
Income statement (P&L) ($ in millions)
| 12/31/2021 TTM | 12/31/2020 | ||
|---|---|---|---|
| Revenues | 171 | ||
| Revenue from related parties | 29 | ||
| Cost of revenue | (85) | ||
| Gross profit: | 86 | ||
| Operating expenses | (273) | ||
| Other undisclosed operating income | 0 | ||
| Operating loss: | (187) | ||
| Nonoperating income | 25 | ||
| Other undisclosed income from continuing operations before equity method investments, income taxes | 0 | ||
| Loss from continuing operations before equity method investments, income taxes: | (162) | ||
| Other undisclosed income from continuing operations before income taxes | 4 | ||
| Loss from continuing operations before income taxes: | (158) | ||
| Income tax benefit | 4 | ||
| Net loss: | (155) | ||
| Other undisclosed net income attributable to parent | 30 | ||
| Net loss available to common stockholders, diluted: | (125) | ||
Comprehensive Income ($ in millions)
| 12/31/2021 TTM | 12/31/2020 | ||
|---|---|---|---|
| Net loss: | (155) | ||
| Other comprehensive loss | (0) | ||
| Comprehensive loss, net of tax, attributable to parent: | (155) | ||
Statements sources
The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.